Remebot robot-assisted stereotactic biopsy (a report of 12 cases)
WU Shi-qiang
JIAO Li-wu
XIAO Qun-gen
LI Yu
LI Chao-xi
GAN Chao
SHU Kai
LEI Ting
Abstract：Objective To explore the clinical values of Remebot robot-assisted stereotactic biopsy to the diagnosis of intracranial lesions. Methods Remebot robot-assisted stereotactic biopsy was performed in 12 patients with intracranial lesions including 1 with frontal lobe lesion in 1 patient, 2 with temporal lobe lesions, 2 with parietal lobe lesions, 2 with brainstem and thalamus lesions and 5 with multiple intracranial regions lesions from October, 2016 to February, 2017. Results All the biopsy was successfully performed and the operative duration was (29 ± 5) minutes. The postoperative pathological results showed that of 12 patients with intracranial lesions, 4 had low grade astrocytomas, 5 with anaplastic astrocytomas (WHO grade Ⅲ), 1 neuroblastoma, 1 pseudoprogression and 1 non-Hopkin's B cell lymphoma. There was symptomatic postoperative bleeding in 1 patient. Conclusions The Remebot robot-assisted stereotactic biopsy is an important medical auxiliary technology in the patients with intracranial lesions and should be clinically spread widely because it can reduce the patients' pain, simplify the procedure of operation, enhance the accuracy of operation, provide the basis for next step the treatment and shorten the operative time.
Keywords：RoboticsStereotactic biopsyIntracranial lesionsDiagnosis
Publication Date：2017-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 751-753 )